Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials
Michele Fornaro,1,2 Marco Solmi,3–5 Giampaolo Perna,2,6 Domenico De Berardis,2,7 Nicola Veronese,5,8 Laura Orsolini,2,9 Licinia Ganança,1,10 Brendon Stubbs11,12 1New York State Psychiatric Institute, Columbia University, New York City, NY, USA; 2Polyedra Research Group®...
Guardado en:
Autores principales: | Fornaro M, Solmi M, Perna G, De Berardis D, Veronese N, Orsolini L, Ganança L, Stubbs B |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01b547c7a5a14b5b9dc87b7a7909db7e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
por: Guerdjikova AI, et al.
Publicado: (2016) -
Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies
por: Citrome L, et al.
Publicado: (2018) -
Binge Eating Disorder in Patients with Type 2 Diabetes: Diagnostic and Management Challenges
por: Chevinsky JD, et al.
Publicado: (2020) -
Impact of Bariatric Surgery on the Healthy Eating Index, Binge Eating Behavior and Food Craving in a Middle Eastern Population: A Lebanese Experience
por: Jana Jabbour, et al.
Publicado: (2021) -
Prevalence of Binge-Eating Disorder and Its Association with Nicotine Dependence Among Under-Graduate Students at a Saudi Public University
por: Bin Abdulrahman KA, et al.
Publicado: (2021)